Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Preparation method of bazedoxifene

A technology of bazedoxifene and oxygen, which is applied in the field of preparation of a new generation of selective estrogen receptor modulator bazedoxifene, can solve the problems of difficult acquisition of raw materials, many reaction steps, and high pressure on environmental protection, and achieve product The yield and product purity are high, and the preparation process is fast and convenient.

Active Publication Date: 2014-05-07
SUZHOU LIXIN PHARMA
View PDF6 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0013] Analyzing the disclosed preparation methods of bazedoxifene and its intermediates, there are generally disadvantages such as difficult to obtain raw materials, many reaction steps, high pressure on environmental protection, and high cost. Therefore, a simpler, more convenient, environmentally friendly and cost-controllable process route is sought , which is crucial to the economic and technological development of this API

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method of bazedoxifene
  • Preparation method of bazedoxifene
  • Preparation method of bazedoxifene

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0031] Under nitrogen protection, add 1-(4-methoxy-phenyl) propyne (II) (1.46g, 10mmol), N-[4-(2-azepan-1-yl) in the reaction flask -ethoxy-benzyl)]-N-[4-(methoxyphenyl)]hydrazine (III) (6.64g, 18mmol), bis(dimethylamino)bis(pentafluorobenzenethiol) ( Dimethylamino)titanium (76.5 mg, 0.2 mmol) and 50 mL of toluene were heated up to 100° C. and stirred for 36 hours. Anhydrous zinc chloride (4.1 g, 30 mmol) was added, the temperature was raised to reflux, and the reaction was continued for 24 hours, and TLC detected that the reaction was complete. The reaction solution was concentrated, dissolved in dichloromethane, washed twice with water, the organic phase was dried over anhydrous sodium sulfate, and the solvent was removed under reduced pressure. The crude product was recrystallized from ethanol to obtain off-white solid 1-[4-(2-azepan-1-yl-ethoxy-benzyl)]-2-(4-methoxy-phenyl)- 3-Methyl-5-methoxy-1H-indole (IV) 3.8g, yield 76.3%.

Embodiment 2

[0033] Under nitrogen protection, 1-(4-benzyloxy-phenyl) propyne (II) (2.22g, 10mmol), N-[4-(2-azepan-1-yl) -Ethoxy-benzyl)]-N-[4-(benzyloxyphenyl)]hydrazine (III) (9.0g, 20mmol), bis(dimethylamino)bis(pentafluorobenzenethiol) ( Dimethylamino)titanium (76.5 mg, 0.2 mmol) and 50 mL of toluene were heated up to 100° C. and stirred for 40 hours. Anhydrous zinc chloride (4.1g, 30mmol) was added, the temperature was raised to reflux, and the reaction was continued for 20 hours, and TLC detected that the reaction was complete. The reaction solution was concentrated, dissolved in dichloromethane, washed twice with water, the organic phase was dried over anhydrous sodium sulfate, and the solvent was removed under reduced pressure. The crude product was recrystallized from ethanol to obtain off-white solid 1-[4-(2-azepan-1-yl-ethoxy-benzyl)]-2-(4-benzyloxy-phenyl)- 5.1 g of 3-methyl-5-benzyloxy-1H-indole (IV), yield 78.5%.

Embodiment 3

[0035] Under nitrogen protection and at -78°C, add 1-[4-(2-azepan-1-yl-ethoxy-benzyl)]-2-(4-methoxy-benzene base)-3-methyl-5-methoxy-1H-indole (IV) (2.5g, 5mmol) and dichloromethane 25mL. Under stirring, a solution of boron tribromide (2.5 g, 10 mmol) in 25 mL of dichloromethane was added dropwise, and the reaction was carried out at room temperature for 10 hours. The reaction was quenched by adding saturated ammonium chloride solution, and the organic layer was separated, dried and concentrated under reduced pressure. The residue was recrystallized from ethyl acetate and n-hexane (1 / 1) to obtain 2.0 g of off-white solid bazedoxifene (I), with a yield of 85.1%.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a preparation method of bazedoxifene. The preparation method of the bazedoxifene comprises the following steps: taking 1-(4-Pg1oxy-phenyl)-allylene (II) and N-[4-(2-azacycloheptane-1-yl- ethyoxyl-benzyl)]-N-[4-(Pg2 oxyphenyl)] hydrazine (III) to perform addition cyclization reaction and acquire 1-[4-(2-azacycloheptane-1-yl- ethyoxyl-benzyl)]-2-(4-Pg1oxy-phenyl)-3-methyl-5-(Pg2oxy)-1H-benzpyrole (IV); performing deprotection on an intermediate (IV) to prepare bazedoxifene (I). The preparation method is simple in process, high in yield, economical and environmental-friendly, so that a novel preparation method for industrial production of the bazedoxifene.

Description

technical field [0001] The invention belongs to the technical field of organic synthesis route design and preparation of raw materials and intermediates, and in particular relates to a preparation method of bazedoxifene, a new generation of selective estrogen receptor modulator. Background technique [0002] Bazedoxifene is a small molecule drug originally developed by Wyeth and later acquired by Pfizer. Bazedoxifene was first listed in Italy and Spain through the approval of the European Medicines and Drug Administration (EMEA) in April 2009, with the trade name Conbriza; in July 2010, it was launched in Japan with the trade name Viviant; in October 2013, it was approved by the US Food and Drug Administration. Approved by the Food and Drug Administration (FDA), it is marketed in the United States under the trade name Duavee for the treatment of moderate to severe menopause-related vasomotor symptoms (hot flashes) and the prevention of postmenopausal osteoporosis in postmeno...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D209/12
CPCY02P20/55C07D209/12
Inventor 许学农张青舒亮谢玲玲任新年苏爱蓉
Owner SUZHOU LIXIN PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com